相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 库存:
100
- 国食药监械注册号:
无
- 保修期:
12个月
- 现货状态:
3天
- 供应商:
玉研科学仪器公司
小动物肺部液体雾化给药器 YAN-30012型
玉研仪器公司专业研制十三年,权威报告实现精细化粒径范围,定量有效到达肺部提高药量精性,减少药物浪费。支持气溶胶或干粉药物,高分文献数量多。

· 定量 QUANTIFIABLE:将定量的气溶胶给到动物肺部
· 定时 TIMED:可以在一个或多个时间点进行给药
· 有效 EFFECTIVE:气溶胶的吸收效果好,给药快速,效率高,操作方便
· 方便 CONVENIENCE:维护简单,操作方便
详细介绍
专业研制十三年,权威报告实现精细化粒径范围,定量有效到达肺部提高药量精性,减少药物浪费。支持气溶胶或干粉药物,高分文献量多。肺部液体雾化给药器是上海玉研仪器专门为小鼠、大鼠、豚鼠等小动物研发设计,可精确进行气管内雾化给药的装置。可将定量液体通过集成在不锈钢毛细插管中的气溶胶雾化微喷头雾化,毛细插管可深入动物至支气管分叉处,实现气管内定量雾化成气溶胶给药。相较于传统口服或注射给药,药物可直接作用于肺部,适用于肺部生理、病理、药理学研究。

优势特点
1、适用于小鼠、大鼠、豚鼠、兔子等小动物,也可定制大动物专用款3、微量精确给药,最小药物用量25μL(液体)
4、可用于溶液、小细胞悬浮液、均质悬浊液、粘度较低的乳浊液、干粉等给药
5、90%药物雾化直径≤30μm(液体),可达终末细支气管甚至呼吸性细支气管,可均匀分布于大小鼠肺部组织中
6、使用方便,安全稳定,采用不锈钢材质,坚固稳定耐腐蚀
7、具有至少30篇高影响因子SCI文献发表,可提供至少1篇IF大于35分的SCI文献
8、设备具有CE认证证书或EC符合性证书
9、可用于吸入毒理学、空气生物学、生物危害测试、吸入免疫、吸入治疗、药物研究、环境评价、危害评估和医学防护等多领域
气管内给药示意图

小动物喉镜
SR310型小动物喉镜,用于观察实验动物的喉部等结构,以进行肺部给药、经口气管插管等操作,适用于小鼠、大鼠、豚鼠,也可根据您的要求进行定制。采用光纤LED照明系统,提供清晰明亮的光线,给观察喉部、会厌等结构的操作人员提供了更好的视野。前端为不锈钢的叶型尖端,可随时拆卸或更换。操作柄的形状符合人体工程学,使操作更舒适方便。

部分用户名单:

敬请关注玉研仪器微信号:

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验参考文献:
1.Zhu, Chuanda, et al. "An elastase nanocomplex with metal cofactors for enhancement of target protein cleavage activity and synergistic antitumor effect." Chemical Engineering Journal (2024): 149902.doi:10.1016/j.cej.2024.149902.
2.Zhu, Chuanda, et al. "An elastase nanocomplex with metal cofactors for enhancement of target protein cleavage activity and synergistic antitumor effect." Chemical Engineering Journal (2024): 149902,doi:10.1016/j.cej.2024.149902
3.Han, Meng-Meng et al. “Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling.” Journal of controlled release : official journal of the Controlled Release Society vol. 366 (2024): 732-745. doi:10.1016/j.jconrel.2024.01.032
4.Feng, Xin et al. “First magnetic particle imaging to assess pulmonary vascular leakage in vivo in the acutely injured and fibrotic lung.” Bioengineering & translational medicine vol. 9,2 e10626. 29 Nov. 2023, doi:10.1002/btm2.10626
5.Fan, Weiyang et al. “Naringenin regulates cigarette smoke extract-induced extracellular vesicles from alveolar macrophage to attenuate the mouse lung epithelial ferroptosis through activating EV miR-23a-3p/ACSL4 axis.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 124 (2024): 155256. doi:10.1016/j.phymed.2023.155256
6.Li, Cheng et al. “Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.” Cell vol. 185,8 (2022): 1389-1401.e18. doi:10.1016/j.cell.2022.03.009
7.Liu, Chang et al. “An Inhalable Hybrid Biomimetic Nanoplatform for Sequential Drug Release and Remodeling Lung Immune Homeostasis in Acute Lung Injury Treatment.” ACS nano vol. 17,12 (2023): 11626-11644. doi:10.1021/acsnano.3c02075
8.Peng, Boya et al. “Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapy.” Journal of extracellular vesicles vol. 11,4 (2022): e12187. doi:10.1002/jev2.12187
9.Yang, Guang, et al. "Noncovalent co-assembly of aminoglycoside antibiotics@ tannic acid nanoparticles for off-the-shelf treatment of pulmonary and cutaneous infections." Chemical Engineering Journal 474 (2023): 145703.do:10.1016/j.cej.2023.145703.
10.Santin, Yohan et al. “Inhalation of acidic nanoparticles prevents doxorubicin cardiotoxicity through improvement of lysosomal function.” Theranostics vol. 13,15 5435-5451. 2 Oct. 2023, doi:10.7150/thno.86310
11.Sun, Han et al. “Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome.” Theranostics vol. 13,14 4974-4992. 4 Sep. 2023, doi:10.7150/thno.86466
12.Yue, Dayong et al. “Diesel exhaust PM2.5 greatly deteriorates fibrosis process in pre-existing pulmonary fibrosis via ferroptosis.” Environment international vol. 171 (2023): 107706. doi:10.1016/j.envint.2022.107706
13.Zhang, Mengjun et al. “Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment.” Journal of controlled release : official journal of the Controlled Release Society vol. 352 (2022): 422-437. doi:10.1016/j.jconrel.2022.10.020
14.Gu, Peiyu et al. “Protective function of interleukin-22 in pulmonary fibrosis.” Clinical and translational medicine vol. 11,8 (2021): e509. doi:10.1002/ctm2.509
15.Wu, Lan et al. “Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration.” ACS applied materials & interfaces vol. 13,3 (2021): 3722-3737. doi:10.1021/acsami.0c21259
16.Tian, Xidong et al. “Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.” ACS applied materials & interfaces vol. 13,48 (2021): 56858-56872. doi:10.1021/acsami.1c16351
17.Lin, Wei-Ting et al. “Modulation of experimental acute lung injury by exosomal miR-7704 from mesenchymal stromal cells acts through M2 macrophage polarization.” Molecular therapy. Nucleic acids vol. 35,1 102102. 14 Dec. 2023, doi:10.1016/j.omtn.2023.102102
18.Yang, Huilin et al. “Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice.” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 139 (2021): 111569. doi:10.1016/j.biopha.2021.111569
19.Feng, Xin et al. “First magnetic particle imaging to assess pulmonary vascular leakage in vivo in the acutely injured and fibrotic lung.” Bioengineering & translational medicine vol. 9,2 e10626. 29 Nov. 2023, doi:10.1002/btm2.10626
20.Xiao, Xue et al. “SerpinB1 is required for Rev-erbα-mediated protection against acute lung injury induced by lipopolysaccharide-in mice.” British journal of pharmacology vol. 180,24 (2023): 3234-3253. doi:10.1111/bph.16175
21.Su, Ruonan et al. “Venetoclax nanomedicine alleviates acute lung injury via increasing neutrophil apoptosis.” Biomaterials science vol. 9,13 (2021): 4746-4754. doi:10.1039/d1bm00481f
22.Xu, Yingying et al. “PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA.” Drug delivery vol. 30,1 (2023): 2219870. doi:10.1080/10717544.2023.2219870
23.Wu, Yanqi et al. “SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation.” Respiratory research vol. 21,1 130. 27 May. 2020, doi:10.1186/s12931-020-01372-6
Chen, Huanjie et al. “Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats.” Frontiers in pharmacology vol. 13 1070736. 6 Jan. 2023, doi:10.3389/fphar.2022.1070736
,是一类采用X 线成像原理进行超高分辨率三维成像的设备。MicroCT能够在不破坏样品的前提下,对骨骼、牙齿、活体小动物和各种材料样品进行高分辨率(根据已知密度的标准品(体模),还能够得到样品内部各点的密度值,推断物质的种类、组成、强度和完整性等参数,例如,计算骨骼的骨矿物质含量。在三维图像的基础上,利用有限元生物力学分析软件,能够分析通常需要在力学试验机上才能够进行的拉伸、压缩、剪切、弯曲和扭转等力学特性,得到弹性模量、泊松比、惯性矩、Von Mises应力和主应变等参数。将 MicroCT得到
高效。越是要你用模糊智慧去想去回味去条件判断分支,就越低效。每个人会有每个人的 workflow,没有一个软件或者做法是能适应所有有的 workflow 的,这也是为什么有的人喜欢 Zotera,有的人喜欢 Papers,有的人喜欢 EndNote。这是我以下摆任何理由的前提,即:摆得出很多理由,但不代表这就是普遍正确的做法。现在我介绍一下我的做法。我的文件夹里最多有两千多篇 paper 的 PDF。我是使用 Windows 系统和 EndNote。 二、我先简单评价一下我用过的其他文献
作用?这些都是在我们选择抗体前需要思考的问题。 如果手头已经有一种可用于传统免疫组化(IHC)的抗体,可以从这些抗体入手。而抗体搜索引擎(例如 CiteAb)是发现所需标志物抗体的下一步工具。搜索引擎可以帮助识别具有最完整验证数据和引文支持性能的抗体信息。咨询病理学家和检测专家,进一步了解所选抗体是否适合多重荧光免疫组化。对于多重荧光免疫组化检测方法,单克隆抗体通常能提供更低的背景信号、更高的特异性和更低的批次差异[2]。 c 使用对照组织验证所选择的抗体组合 选择正确的阳性和阴性












